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Abstract
SIADH is more commonly associated with small cell lung cancer but has also been associated with other malignancies
such as oropharyngeal, gastrointestinal, genitourinary, endocrine, lymphomas, and sarcomas. There have been few reports of small cell carcinoma of the cervix complicated by SIADH; however, not many cases are associated with squamous cell carcinoma of the cervix. We present a case of a patient with squamous cell carcinoma of the cervix with a
paraneoplastic syndrome of inappropriate secretion of antidiuretic hormone. The pathophysiology, clinical picture, and
treatment are also discussed.
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1. Introduction

P

araneoplastic syndromes (PNS) are known rare
disorders that range in presentation but essentially are an abnormal immunological response to
tumors or malignancies or excessive production of a
hormone. These syndromes are more commonly
seen in lung, ovarian, lymphatic, and breast cancers.
Syndrome of inappropriate antidiuretic hormone
(SIADH) secretion can be a paraneoplastic process
and occurs in 10%e45% of small cell lung cancer.1e3
Most SIADH cases have been associated with small
cell lung cancer. In contrast, associations between
SIADH and gynecological malignancies are rare,
with only a small number of cases reported in small
cell carcinoma of the cervix and one case in squamous cell carcinoma of the cervix.5e7 We present
here the second known case of squamous cell carcinoma of the cervix complicated with SIADH.

2. Case report
This is an 84-year-old G9P5 female with a past
medical history of hypertension, vertigo, pre-diabetes, and newly diagnosed p16 positive-HPV
associated squamous cell carcinoma of the cervix by
colposcopy (Fig. 1). The patient was sent to the
hospital for pelvic examination under anesthesia for
clinical staging of the cancer. The patient denied
past surgical history or known family history of
cancer. She denied any smoking history, alcohol, or
illicit drug use. The patient denied receiving daily
diuretics and was only taking Nifedipine 30 mg,
Losartan 100 mg, vitamin b12 and aspirin 81 mg.
Denied the use of any other medications. Additionally, the patient denied drinking excessive
amounts of water or ﬂuids.
The patient was hemodynamically stable with
blood pressure 115/80 mmHg, with positive orthostasis, heart rate 98 beats per minute, and temp 36.5
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Figure 1. Cervical biopsy showing squamous cell cancer with positive p16 staining.

Celsius. On the physical exam, the patient was
euvolemic with moist mucous membranes, no lower
extremities edema and normal breath sounds. Initial
preoperative labs were signiﬁcant for hyponatremia
of 127 mEq/L, potassium 4.3mEq/L, chloride 94 mE/
L, blood urea nitrogen 14 mg/dL, Creatinine
1.20 mg/dL. The patient's baseline sodium based on
prior labs was 132 mEq/L. Complete blood count
showed white blood count of 7.1  10^3/mm3
without any left shift, hemoglobin of 13.3 g/dL, hematocrit of 40.0% and platelet count of 399 K/mm3.
The patient was admitted for further work-up and
correction of hyponatremia. She was initially started
on intravenous normal saline with an appropriate
maintenance ﬂuid adjusted for her weight. However, the ﬂuid infusion was discontinued when
repeated laboratory tests showed a worsening drop
in sodium concentration to 125 mEq/L.
Subsequent labs which were drawn prior to ﬂuid
initiation showed serum osmolality of 272 mOsm/
Kg, urine osmolality of 357 mOsm/Kg, urine sodium
of 74 mmol/L. The patient had normal renal function and morning cortisol and TSH levels were
within normal limits, excluding adrenal insufﬁciency and hypothyroidism as causes for her hyponatremia (Table 1). There was no evidence of acidbase disorders. The patient's laboratory studies were
consistent with a diagnosis of SIADH. Ultimately,
the patient was placed on a ﬂuid restriction of less
than 1 L/day, and her sodium level improved to 130
mEq/L, which appeared to be closer to her baseline.

CT chest, abdomen, pelvis without contrast was
obtained for staging purposes and revealed no
convincing evidence of metastatic disease. Subsequently, she was able to tolerate general anesthesia
for clinical staging through cystoscopy and proctosigmoidoscopy with biopsies. The ﬁnal stage of her
cancer was determined to be cervical cancer stage
1B1. After the procedure, the patient remained on a
ﬂuid-restricted diet, and sodium level further
improved to 132 mEq/L on the day of discharge. The
patient was ultimately discharged and was instructed to follow up with the primary clinic for newly
diagnosed SIADH, follow up with OB-GYN and
oncology for initiation of radiation, and was advised
to limit ﬂuid intake to less than 1 L per day. The
Table 1. Patient's baseline data.
AM Cortisol
TSH
Sodium
Potassium
Chloride
BUN
Creatinine
WBC
Hgb
HCT
Platelets
Serum osmolality
Urine osmolality
Urine Sodium

Value

Reference Range

10.3 mcg/dL
1.881 uIU/mL
127 mEq/L
4.3 mEq/L
94 mE/L
14 mg/dL
1.20 mg/dL
7.1  10^3/mm3
13.3 g/dL
40.0%
399 K/mm3
272 mOsm/kg
357 mOsm/kg
74 mmol/L

4.3e22.4 mcg/mL
0.450e5.330 uIU/mL
135-145 mEq/L
3.5e5.0 mEq/L
98-107 mE/L
7e23 mg/dL
0.60e1.30 mg/dL
4.5e11.0^3/mm3
12.0e16.0 g/dL
36.0e46.0%
140e440 K/mm3
283e299 mOsm/kg
50-1200 mOsm/kg
15e237 mmol/L

patient received her ﬁrst radiation therapy, and her
follow-up labs were obtained nine days after the
session, revealing signiﬁcant improvement of her
sodium level to 137 mEq/L, which is the highest
sodium level the patient had based on prior labs.

3. Discussion
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) occurs when there is an
increase of arginine, vasopressin, or other similar
peptide causing intravascular water retention, and
hyponatremia.2 SIADH is a rare paraneoplastic
syndrome (PNS) that can be present in a variety of
malignancies; however, some malignancies have a
higher incidence of SIADH than others. For
instance, SIADH is most associated with lung cancer, speciﬁcally accounting for 10%e45% with small
cell lung carcinoma (SCLC).1e3 Occasionally,
SIADH can precede the diagnosis of SCLC, and
generally is associated with a worse prognosis.4 In
contrast, SIADH rarely presents in cervical cancer.5
Small cell carcinoma of the cervix is a rare malignant tumor, and it is estimated that 10% of this
cancer may present with symptoms of neuroendocrine tumor (most commonly SIADH).1e6 SIADH is
rarely reported in patients with non-small cell lung
cancer (NSCLC).4 Over the past twenty years, only
three cases of SIADH have been reported in patients
with NSCLC.4 Additional cancers with SIADH
include lymphoma, mesothelioma, thymoma,
Ewing's sarcoma, and squamous cell carcinoma
(SCC) of the head and neck.16 Per literature review,
the PNS of SIADH has been identiﬁed in squamous
cell carcinoma (SCC) of head and neck as well as the
respiratory tract; however, only one case of SIADH
has been reported for SCC of the cervix.5e7 Our
patient represents the second reported case of
SIADH presenting in squamous cell carcinoma of
the cervix, a rare phenomenon.
The pathophysiology of SIADH in small cell lung
cancers has been well identiﬁed. The mechanism is
considered due to ectopic antidiuretic hormone
(ADH) production by malignant cells that is independent of a negative feedback loop.4 In a study of
patients with SCLC, both ADH and atrial sodium
diuretic peptide (ANP) were shown to result in
SIADH. It has also been noted that ADH is more
closely related to the development of hyponatremia.8 In contrast, for patients who develop
SIADH secondary to a malignancy other than SCLC,
as with our patient, the etiology is not currently well
understood.
Many theories have been documented to explain
the mechanism of SIADH in cancers other than
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SCLC. It was proposed that the etiology of hyponatremia was not due to hormonal release, as NSLC
rarely has been shown to produce ADH or ANP
polypeptide hormones.4e9 Further studies in SCC
tumors, as in our patient, did not demonstrate ADH
gene expression.10 Therefore, the mechanism of
how our patient with cervical SCC developed
SIADH remains a mystery.
In general, PNS is rarely present in gynecological
primary cancers, especially cervical cancer.5 For
instance, for patients with small cell carcinoma of the
cervix, it has been hypothesized that polypeptide
hormones are secreted by the tumor in inactive
forms and or in insufﬁcient amounts to lead to a
paraneoplastic syndrome.5e12 In contrast, studies
have shown that there are neuropeptides thought to
be associated with ADH production in squamous cell
carcinoma.10 In animal studies, mice vaccinated with
squamous cell carcinoma showed increased levels of
neuropeptide Y, which caused increased stimulation
of the posterior pituitary gland and led to the
secretion of ADH hormone.10e14 More recent studies
report that higher levels of ADH in SCC (in 38% of
SIADH patients with SCC) may suggest that ADH is
stimulated indirectly through neuropeptide Y in patients with SCC, in comparison to direct stimulation
of ADH with SCLC.10e15 Therefore, it is important to
identify the histopathology and origin of tumor in
patients presenting with PNS to fully understand the
mechanism of the paraneoplastic process. Our patient underwent biopsies not only for clinical staging,
but also to identify the source of ADH release.
Relevant alternative theories to explain the etiology of such paraneoplastic syndrome have been
reported. In one case report, a patient with NSCLC
developed SIADH after completion of radiation
therapy. It was hypothesized that the PNS was
secondary to release of ADH from tumor lysis.4e16
There are also several reports that SIADH is
induced by certain chemotherapy for other types of
cancers, such as Cisplatin infusion. Levine et al.
suggested that Cisplatin administration induces
SIADH by excessive central antidiuretic hormone
secretion as well as via direct renal tubular injury.2
Regardless, our patient did not receive radiation or
chemotherapy prior to the diagnosis of such paraneoplastic syndrome.
When determining the prognosis of cervical SCC
complicated by SIADH, we have limited information
due to its rare occurrence. Paraneoplastic syndromes
can be the ﬁrst sign of malignancy, and can precede it
by months to years, which requires further evaluation.4 Hyponatremia may be a useful tool in early
diagnosis of malignancy; however, it may indicate a
poor prognosis.1 On the other hand, if the
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hyponatremia from SIADH allows for early diagnosis
of the malignancy and patients are treated adequately
with surgical excision of the tumor (if applicable), this
may lead to better outcomes and subsequent
improvement in the electrolyte disturbances of
SIADH.1e5 In terms of treatment of patients with
SIADH secondary to malignancy, or in patients with
SIADH in general, the overall goal of therapy is to treat
the underlying condition. Therefore, patients exhibiting paraneoplastic SIADH should undergo treatment
of their malignancy.5e17 In our case, the patient's sodium levels normalized within 2 weeks following radiation, consistent with treatment of the underlying
condition in order to treat SIADH. Further research is
warranted in order to investigate the prognostic effect
and therefore signiﬁcance of early detection to treat
this paraneoplastic disorder.
There are several barriers in our case, as SIADH
can occur via idiopathic cause or can occur following
head trauma, surgery, medications (e.g. morphine,
NSAIDs, and oxytocin), various lung diseases
(pneumonia, abscess and tuberculosis) and/or due
to endocrine disease states (hypothyroidism and
glucocorticoid deﬁciency).18 However, we were unable to identify these alternative causes in our patient. It is unclear whether SIADH was a
paraneoplastic syndrome or an incidental idiopathic
ﬁnding. Further research is warranted to conﬁrm
and diagnose the possibility of paraneoplastic syndrome in patients with cervical SCC.

4. Conclusion
We identiﬁed a rare case of SCC of the cervix
demonstrating the paraneoplastic syndrome
SIADH, an unexpected ﬁnding. This case aims to
identify possible etiologies of this paraneoplastic
syndrome, perform thorough literature review of
this phenomenon, and edify the importance of
immunohistological analysis of these tumors.
SIADH may provide prognostic information for
these patients and may lead to earlier diagnosis and
treatment. Our case supports prior evidence that
treatment of the underlying malignancy remains the
best management to improve paraneoplastic syndromes such as SIADH. The mechanism of SIADH
in cancers other than SCLC continues to warrant
further research.
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